SEI Medical PCL (SEI.BK) Stock Price

SEI Medical PCL Price

CLOSED
1.97
​
Market closed

Revenue has compounded at 12.1% per year over the past 3 years to 447.52 M THB. Earnings per share have grown at 37.6% per year over the last 3 years. SEI Medical PCL's net margin stands at 10.4%, up from 5.6% several years earlier. SEI Medical PCL currently offers a dividend yield of about 6.09%. The payout ratio is around 44% of earnings.

SEI Medical PCL stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SEI Medical PCL business model & stock analysis

SEI Medical PCL generates revenue through the distribution and leasing of medical equipment and laboratory instruments. The company's primary products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment, and laboratory equipment, sold across its Scientific equipment and medical equipment segments. Service contracts form another key revenue stream, covering maintenance and support for medical devices. The firm serves healthcare providers and institutions requiring diagnostic and treatment solutions, leveraging its Bangkok headquarters to operate within Thailand's medical sector. The company's business model focuses on selling scientific and medical equipment, offering service contracts, and providing medical equipment lease agreements. Its segments are clearly defined as Scientific equipment and medical equipment, with service as a separate offering. Revenue is derived from direct sales to hospitals, clinics, and laboratories, as well as from long-term lease contracts. The firm's IPO on September 24, 2024, marks its entry into public markets, though it continues to rely on its established distribution network for growth. SEI Medical PCL's core operations involve the sale of specialized medical equipment including endoscopy, surgical, and neonatal care devices, alongside laboratory instruments. The service segment provides essential maintenance and technical support, enhancing customer retention. The company targets healthcare facilities seeking comprehensive solutions for diagnostic and therapeutic procedures, positioning itself as a key supplier in Thailand's medical equipment market.

Frequently asked questions about SEI Medical PCL

Converted at the current exchange rate, the SEI Medical PCL share trades at 0.05 EUR (1.97 THB).

The revenue cannot currently be calculated for SEI Medical PCL.

The expected profit of SEI Medical PCL is 71.40 M THB. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of SEI Medical PCL is currently 4.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SEI Medical PCL stock.

The P/S cannot be calculated for SEI Medical PCL currently.

The Eulerpool Quality Score for SEI Medical PCL is 4/10.

The ISIN of SEI Medical PCL is THC265010007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of SEI Medical PCL is SEI.BK. The ticker symbol is used to trade SEI Medical PCL shares on the stock exchange.

Fair ValueTerminal
1.75 THB
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website sei.co.th
Country
Thailand
Currency
THB
Initial public offering
Sep 24, 2024
ISIN
THC265010007
Cusip
Y7570E115
Market capitalization
334.90 M THBSmall Cap
52-Week Range
SEI Medical PCL Directors Dealings
Quality Investing
5 / 10
PEG
—
P/E ratio
P/Ee 2026
4.69
P/Ee 2027
—
P/S
P/Se
—
EV/EBIT
2.85
P/B Ratio
1.07
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
14.63 %
Dividend
Dividend yield
6.09 %
Est. Dividend Yield
6.09 %
Payout Ratio
43.87 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
1 year
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
10.00 %
Last updated Oct 25, 2026, 1:18 AM

SEI Medical PCL Peer Group

All fundamentals and in-depth analysis of SEI Medical PCL

Our stock analysis for SEI Medical PCL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SEI Medical PCL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

SEI Medical PCL
SEI Medical PCL Revenue→
SEI Medical PCL
SEI Medical PCL Net Income→
SEI Medical PCL
SEI Medical PCL P/E→
SEI Medical PCL
SEI Medical PCL P/S→
SEI Medical PCL
SEI Medical PCL EBIT→
SEI Medical PCL
SEI Medical PCL Dividend→
SEI Medical PCL
SEI Medical PCL Directors Dealings→
SEI Medical PCL
SEI Medical PCL Stocks→
SEI Medical PCL
SEI Medical PCL Market capitalization→
SEI Medical PCL
SEI Medical PCL Debt→
SEI Medical PCL
SEI Medical PCL Liabilities→
SEI Medical PCL
SEI Medical PCL Equity→
SEI Medical PCL
SEI Medical PCL AAQS→
SEI Medical PCL
SEI Medical PCL Employees→
SEI Medical PCL
SEI Medical PCL ROE→
SEI Medical PCL
SEI Medical PCL ROA→
SEI Medical PCL
SEI Medical PCL ROCE→
SEI Medical PCL
SEI Medical PCL News→
SEI Medical PCL
SEI Medical PCL Analyst Price Targets→

— Stocks

Seibels Bruce GroupSeetel New Energy CoSejahtera Bintang Abadi Textile Tbk PTSeers Technology CoSekur Private DataSeegnalSelkirk Copper MinesSeed Capital SolutionsSemacom Integrated Tbk PTSecurity Midwest BancorpSemilux InternationalSecuretech InnovationsAll Stocks A–Z →